Our results show that chemotherapy combined with a DNMT inhibitor reduces EMT and improves chemotherapy sensitivity in ESCC cells with low mtDNA and chemotherapy resistance. This evidence concerns the gene DNMT1 and esophageal squamous cell carcinoma.